developed a rash on her arm, to wrist and elbow. It is an itchy red rash, not really hives; developed a rash on her arm, to wrist and elbow. It is an itchy red rash, not really hives; tested positive for Covid, completely vaccinated; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (tested positive for Covid, completely vaccinated), RASH ERYTHEMATOUS (developed a rash on her arm, to wrist and elbow. It is an itchy red rash, not really hives) and RASH PRURITIC (developed a rash on her arm, to wrist and elbow. It is an itchy red rash, not really hives) in a 70-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) tablet for COVID-19.    The patient did not have any other health conditions. The patient did not have diabetes, high blood pressure or anything like that, that would put her at risk, except for her age.    In October 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 28-Feb-2023, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) 3 dosage form twice a day. On 27-Feb-2023, the patient experienced COVID-19 (tested positive for Covid, completely vaccinated). On 02-Mar-2023, the patient experienced RASH ERYTHEMATOUS (developed a rash on her arm, to wrist and elbow. It is an itchy red rash, not really hives) and RASH PRURITIC (developed a rash on her arm, to wrist and elbow. It is an itchy red rash, not really hives). At the time of the report, COVID-19 (tested positive for Covid, completely vaccinated) outcome was unknown and RASH ERYTHEMATOUS (developed a rash on her arm, to wrist and elbow. It is an itchy red rash, not really hives) and RASH PRURITIC (developed a rash on her arm, to wrist and elbow. It is an itchy red rash, not really hives) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2023, SARS-CoV-2 test: Positive. On 03-Mar-2023, SARS-CoV-2 test: Negative.         No concomitant medications were reported.   The patient received all 5 Moderna vaccines including bivalent dose on Oct-2022. The patient was tested positive on Monday 27Feb2023 and started Paxlovid on the next day and took it Wednesday. On 02Mar2023, only took morning dose because she developed a rash on her arm, to wrist and elbow. It was an itchy red rash, not really hives. According to the patient her physician called pharmacist and told her to stop taking it. The patient had mild COVID-19. Five days after, the patient tested herself in the morning and result came as negative. The patient visited urgent care for itchy red rash. It was gone away, not completely gone, but was fading. It was not itchy anymore, was itchy before.  It was reported that, the patient did not have cough or fever but got it anyway.   No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-Mar-2023: Live follow-up information included quality complaint number updated.